N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide
C22H30N4O4 — CID 145087595
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide
N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide (PubChem CID 145087595) has the molecular formula C22H30N4O4 and a molecular weight of 414.51 g/mol. Its IUPAC name is N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide.
Molecular Properties
| Compound Name | N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide |
|---|---|
| PubChem CID | 145087595 |
| Molecular Formula | C22H30N4O4 |
| Molecular Weight | 414.51 g/mol |
| Exact Mass | 414.23 |
| IUPAC Name | N-(2-cyanoethyl)-1-[2-[(2-hydroxy-3-phenylpropanoyl)amino]propanoyl]-N-methylpiperidine-2-carboxamide |
| SMILES | CC(NC(=O)C(O)Cc1ccccc1)C(=O)N1CCCCC1C(=O)N(C)CCC#N |
| InChI | InChI=1S/C22H30N4O4/c1-16(24-20(28)19(27)15-17-9-4-3-5-10-17)21(29)26-14-7-6-11-18(26)22(30)25(2)13-8-12-23/h3-5,9-10,16,18-19,27H,6-8,11,13-15H2,1-2H3,(H,24,28) |
| InChIKey | NOZGZABEWYQPCL-UHFFFAOYSA-N |
| XLogP | 0.85 |
| TPSA | 113.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.51 |
| LogP ≤ 5 | 0.85 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145087595 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.